Results 1 to 10 of about 8,277 (191)

MRI findings in juvenile Huntington's disease

open access: goldRadiology Case Reports, 2021
Juvenile Huntington's disease is a rare neurodegenerative disorder that first affects the basal ganglia. Presented here is a case of juvenile Huntington's disease in an 8-year-old male. Clinical features included epilepsy and developmental delay. Imaging
Patrick Arraj, BS   +4 more
doaj   +4 more sources

Ghosts From the Past: A Juvenile Onset Huntington's Disease Case From Bahrain [PDF]

open access: goldBJPsych Open
Aims Huntington’s disease (HD) is a rare inherited disease in an autosomal dominant pattern, that is most prevalent among Caucasians. Juvenile onset Huntington disease (JHD) is a rare subtype of the disease, defined by presence of the disease by the age
Hanan Husain   +2 more
doaj   +4 more sources

Juvenile Huntington’s disease masquerading as progressive myoclonus epilepsy [PDF]

open access: yesEpilepsy & Behavior Reports, 2021
Juvenile Huntington’s disease (JHD) has an onset before 20 years of age, and is characterized by behavioural issues, epilepsy, rigidity, bradykinesia and dystonia. It contributes to 0.5–5% of all Huntington disease (HD) cases.
Bina Thakor   +2 more
doaj   +2 more sources

Juvenile Huntington’s disease: two case reports and a review of the literature [PDF]

open access: yesJournal of Medical Case Reports, 2020
Background Huntington’s disease is a rare, autosomal dominant neurodegenerative disease characterized by motor, cognitive, and psychiatric symptoms. Usually, the disease symptoms first appear around the age of 40, but in 5–10% of cases, they manifest ...
Sigita Lesinskienė   +5 more
doaj   +2 more sources

Effect of Immersive Virtual Reality by a Computer Assisted Rehabilitation Environment (CAREN) in Juvenile Huntington’s Disease: A Case Report [PDF]

open access: yesMedicina, 2022
Various studies have proven the utility of immersive virtual reality (VR) as a complementary approach to conventional neurorehabilitation therapy for improving neuromuscular and cognitive outcomes in several neurological diseases.
Roberta Cellini   +10 more
doaj   +2 more sources

Case report: Cerebellar sparing in juvenile Huntington's disease [PDF]

open access: goldFrontiers in Neurology, 2023
Juvenile Huntington's disease is an early-onset variant of Huntington's disease, generally associated with large CAG repeats and distinct clinical symptoms. The role of the cerebellum in Huntington's disease has been reevaluated, based on the presence of
Bruno Lopes Santos-Lobato   +3 more
doaj   +2 more sources

Diagnosing Juvenile Huntington’s Disease: An Explorative Study among Caregivers of Affected Children [PDF]

open access: yesBrain Sciences, 2020
Objective: To investigate the reasons for the diagnostic delay of juvenile Huntington’s disease patients in the Netherlands. Methods: This study uses interpretative phenomenological analysis.
Mayke Oosterloo   +3 more
doaj   +2 more sources

Juvenile Huntington’s Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data [PDF]

open access: yesFrontiers in Cell and Developmental Biology, 2021
Polyglutamine (PolyQ) diseases are neurodegenerative disorders caused by the CAG repeat expansion mutation in affected genes resulting in toxic proteins containing a long chain of glutamines.
Karolina Świtońska-Kurkowska   +3 more
doaj   +2 more sources

Juvenile Huntington's disease: a clinical case from a pediatric's practice

open access: diamondКлинический разбор в общей медицине, 2023
Background. Huntington's disease (Hd) is a hereditary neurodegenerative disease with an autosomal dominant type of inheritance and manifested by motor, behavioral and mental disorders.
Emilia E. Alieva   +3 more
doaj   +2 more sources

Generation of two human iPSC lines from dermal fibroblasts of adult- and juvenile-onset Huntington's disease patients and two healthy donors

open access: goldStem Cell Research, 2023
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a mutation in the HTT gene. To generate human-induced pluripotent stem cells (hiPSCs), we used dermal fibroblasts from 1 healthy adult control (K-Pic2), 1 HD manifest ...
Marta Piechota   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy